金天格胶囊联合氨基葡萄糖治疗膝骨关节炎临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R684.3

基金项目:


Clinical Study on Jintiange Capsules Combined with Glucosamine for Knee Osteoar⁃ thritis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察金天格胶囊联合氨基葡萄糖治疗膝骨关节炎(KOA) 的临床疗效。方法:将100 例 KOA 患者随机分为对照组与治疗组各50 例。对照组采用氨基葡萄糖治疗,治疗组采用金天格胶囊联合氨基葡 萄糖治疗。治疗12 周后, 比较2 组不良反应及临床疗效, 以及治疗前后Lysholm 膝关节功能评分 表(Lysholm) 评分、步行能力、炎症因子[白细胞介素-1β (IL-1β)、转化生长因子-β1 (TGF-β1)] 水 平。结果:治疗组总有效率为86.00%,对照组为64.00%,2 组比较,差异有统计学意义(P<0.05)。治疗 12 周,2 组Lysholm 评分均较治疗前及治疗6 周升高(P<0.05),且治疗组在相同时间点Lysholm 评分均高于 对照组(P<0.05)。治疗后,2 组步频、步速、步长均较治疗前升高(P<0.05),双支撑相较治疗前降 低(P<0.05);且治疗组步长值大于对照组(P<0.05),而2 组步频、步速、双支撑相差别不大(P>0.05)。 治疗后,2 组IL-1β 水平较治疗前降低(P<0.05),TGF-β1 水平较治疗前升高(P<0.05);且治疗组IL-1β 水平低于对照组(P<0.05),TGF-β1 水平高于对照组(P<0.05)。治疗过程中,2 组均未发生严重不良反 应。结论:金天格胶囊联合氨基葡萄糖治疗KOA 疗效显著,可明显改善患者膝关节功能及步行能力,降低机 体炎症反应,且安全可靠。

    Abstract:

    Abstract:Objective:To observe the clinical effect of the therapy of Jintiange Capsules combined with Glucosamine on knee osteoarthritis (KOA). Methods: A total of 100 patients with KOA were randomly divided into the control group and the treatment group,with 50 patients in each group. The control group was treated with Glucosamine, and the treatment group was treated with Jintiange Capsules combined with Glucosamine. After 12 weeks of treatment, the adverse reactions and clinical effects in the two groups were compared. Before and after treatment, the scores of Lysholm knee function rating scale (Lysholm),walking ability,and inflammatory factors,including interleukin- 1β (IL- 1β) and transforming growth factor- β1 (TGF- β1), were compared between the two groups. Results: After treatment, the total effective rate was 86.00% in the treatment group and 64.00% in the control group, the difference being significant (P<0.05). After 12 weeks of treatment, the Lysholm scores in the two groups were increased when compared with those before treatment and those after 6 weeks of treatment (P<0.05), and the Lysholm score in the treatment group was higher than that in the control group at the same time point (P<0.05). After treatment,the step frequency,step speed and step length in the two groups were increased when compared with those before treatment (P<0.05),and the doubble supported phase was decreased when compared with that before treatment (P<0.05); the step length in the treatment group was longer than that in the control group (P<0.05), but the step frequency, step speed and doubble supported phase were not significantly different between the two groups (P>0.05). After treatment, the IL- 1β levels in the two groups were decreased when compared with those before treatment (P<0.05), and the TGF-β1 levels were increased when compared with those before treatment (P<0.05);the IL-1β level in the treatment group was lower than that in the control group (P<0.05),and the TGF-β1 level was higher than that in the control group (P<0.05). In the course of treatment, no serious adverse reactions occurred in both groups. Conclusion:The therapy of Jintiange Capsules combined with Glucosamine has a significant therapeutic effect on KOA patients,which can significantly improve the knee joint function and walking ability,and reduce the body inflammatory responses,with a safe and reliable effect.

    参考文献
    相似文献
    引证文献
引用本文

赵海波,李晓林,沈晨啸.金天格胶囊联合氨基葡萄糖治疗膝骨关节炎临床研究[J].新中医,2023,55(24):91-95

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-12-30
  • 出版日期:
文章二维码